Abstract:OBJECTIVE:To study the extent and incidence of sensorineural hearing loss (SNHL) after radiotherapy (RT). METHODS:Twenty-eight patients with diagnosed nasopharyngeal carcinoma (NPC) were selected. The pure-tone audiography, auditory brain stem evoked response (ABR), impedance audiometry and evoked otoacoustic emissions (EOAE) recordings were performed before RT, 1 month, 1, 2 and 5 years after RT. RESULTS:At 1 month after RT, there were 7.1 and 25.7 dB increased mean bone conduction (BC) thresholds at speech (0.5 - 4.0 kHz) and at high frequency (8.0 kHz), and their BC thresholds were statistically significant increase than those before RT, respectively (P < 0.001). At 1 year after RT, there were 17.6 and 28.1 dB increased respectively, and their thresholds were statistically significant increase than those at pre-irradiation (P < 0.001). There were also significant increases in thresholds than those at 1 month of post-irradiation (P <0.001 or P < 0.05). At 2 years after RT, 21 and 27.4 dB were increased at respective those two frequencies, and there was a statistically difference only at speech frequencies when compared with those at 1 year after RT (P < 0.05). At 5 years after RT, 26.7 and 35.8 dB were increased at these two frequencies, and there were significant increases in threshold than those before, 1 month, 1 and 2 years after RT, respectively (P < 0.001). From 1 month to 5 years after RT, 37. 5% to 94. 7% of ears had a BC hearing threshold of at least 15 dB losses at speech frequency, whereas the percentage at high frequency was 85.4 to 97.4%. Up to 63.2% and 73.7% of ears had 30 dB SNHL at least at speech and high frequency, respectively. Furthermore, the degree of mean threshold loss was greater at high frequency than at speech frequency. The mean value of wave I, III and V latency, and I -V interpeak latency intervals of ABR had no significant difference between at 1 month after RT and before RT (P > 0.05). The wave I , III and V latency, and I - V interpeak latency intervals at 1 year and 2 years were significantly prolonged when compared with those before and 1 month after RT (P < 0.05), but there were no significant difference between 1 year and 2 years after RT (P > 0.05). The wave I, III and V latency, and I -V interpeak latency intervals at 5 years after RT were also significantly longer than those before RT (P < 0.001). There were significant difference in wave I , III and V latency (P < 0.05), and no significant difference in wave I - V interpeak latency intervals (P > 0. 05) between 5 years after RT and 1 year or 2 years after RT. Seven of 10 ears at 1 year after RT and 4 of 7 ears at 5 years after RT had normal EOAE, but they all had abnormal ABR response. CONCLUSIONS:SNHL in NPC patients start soon after completion of RT, especially more commonly in high frequency. The incidence and the extent of hearing loss are increased with time of follow-up. The hearing impairment could occur in the cochlea and/or the retrocochlear auditory pathway, which show that the sensitivity of radiation damage may be different in different patient and anatomic site of auditory system.

Diagnosis and treatment on osteoradionecrosis of temporal bone in cases with nasopharyngeal carcinoma after radiotherapy]

[Diagnosis and Treatment on Osteoradionecrosis of Skull Base after Radiotherapy for Nasopharyngeal Carcinoma].

Diagnosis and Management of Skull Base Osteoradionecrosis after Radiotherapy for Nasopharyngeal Carcinoma

Clinical Analysis on Osteoradionecrosis of Skull Base in Patients with Nasopharyngeal Carcinoma after Radiotherapy

Surgical management of radiation-induced temporal lobe necrosis in patients with nasopharyngeal carcinoma: report of 14 cases.

Osteoradionecrosis of Skull Base: Clinical Analysis and Experience

Osteoradionecrosis of the Skull Base in Nasopharyngeal Carcinoma: Incidence and Risk Factors.

Temporal Lobe Necrosis Following Radiotherapy in Nasopharyngeal Carcinoma: New Insight Into the Management

Study of secretory otitis media after radiotherapy in nasopharyngeal carcinoma and inquisition of prevention and treatment

Dynamic MRI Follow-Up of Radiation Encephalopathy in the Temporal Lobe Following Nasopharyngeal Carcinoma Radiotherapy

[Clinical Observation of Sensorineural Hearing Loss in Patients Suffering from Nasopharyngeal Carcinoma after Radiotherapy].

Narrative Review: Temporal Lobe Necrosis after Radiotherapy for Nasopharyngeal Carcinoma

Surgical treatment and prognosis of recurrent and radiotherapy insensitive nasopharyngeal carcinoma

[Important Prognostic Factors in Patients with Skull Base Erosion from Nasopharyngeal Carcinoma after Radiotherapy].

Computed Tomographic Findings of Skull Base Bony Changes after Radiotherapy for Nasopharyngeal Carcinoma: Implications for Local Recurrence.

The influences and treatments of deafness in nasopharyngeal carcinoma patients after radiotherapy

[Clinical classification, staging and treatment strategy of radionecrosis of the nasopharynx and skull base]

Surgical Management of Osteoradionecrosis of the Jaws.

Postradiation Nasopharyngeal Necrosis in the Patients with Nasopharyngeal Carcinoma

Clinical Analysis of 60 Cases with Radiative Nasopharyngeal Necrosis in Nasopharyngeal Carcinoma

Impacts on Hearing in Patients with Nasopharyngeal Cancer by Helical Tomotherapy and chemotherapy and /or Molecular-Targeted Therapy